nodes	percent_of_prediction	percent_of_DWPC	metapath
Mometasone—Skin bacterial infection—Mechlorethamine—lymphatic system cancer	0.332	0.332	CcSEcCtD
Mometasone—Skin depigmentation—Methotrexate—lymphatic system cancer	0.0367	0.0367	CcSEcCtD
Mometasone—Skin striae—Bleomycin—lymphatic system cancer	0.0238	0.0238	CcSEcCtD
Mometasone—Trauma—Bleomycin—lymphatic system cancer	0.0159	0.0159	CcSEcCtD
Mometasone—Impaired healing—Carmustine—lymphatic system cancer	0.0152	0.0152	CcSEcCtD
Mometasone—Haemoptysis—Fludarabine—lymphatic system cancer	0.0139	0.0139	CcSEcCtD
Mometasone—Telangiectasia—Methotrexate—lymphatic system cancer	0.013	0.013	CcSEcCtD
Mometasone—Oral candidiasis—Carmustine—lymphatic system cancer	0.0104	0.0104	CcSEcCtD
Mometasone—Ulcer—Bleomycin—lymphatic system cancer	0.00799	0.00799	CcSEcCtD
Mometasone—Wheezing—Bleomycin—lymphatic system cancer	0.00734	0.00734	CcSEcCtD
Mometasone—Bronchospasm—Teniposide—lymphatic system cancer	0.00724	0.00724	CcSEcCtD
Mometasone—Furunculosis—Methotrexate—lymphatic system cancer	0.00719	0.00719	CcSEcCtD
Mometasone—Leukoderma—Methotrexate—lymphatic system cancer	0.00719	0.00719	CcSEcCtD
Mometasone—Impaired healing—Methotrexate—lymphatic system cancer	0.00706	0.00706	CcSEcCtD
Mometasone—Contusion—Mitoxantrone—lymphatic system cancer	0.00703	0.00703	CcSEcCtD
Mometasone—Viral infection—Mitoxantrone—lymphatic system cancer	0.00679	0.00679	CcSEcCtD
Mometasone—Bacterial infection—Methotrexate—lymphatic system cancer	0.00662	0.00662	CcSEcCtD
Mometasone—Ulcer—Mitoxantrone—lymphatic system cancer	0.00648	0.00648	CcSEcCtD
Mometasone—Musculoskeletal pain—Vincristine—lymphatic system cancer	0.00637	0.00637	CcSEcCtD
Mometasone—Candida infection—Carmustine—lymphatic system cancer	0.0063	0.0063	CcSEcCtD
Mometasone—Furuncle—Methotrexate—lymphatic system cancer	0.00623	0.00623	CcSEcCtD
Mometasone—Bronchitis—Fludarabine—lymphatic system cancer	0.00622	0.00622	CcSEcCtD
Mometasone—Upper respiratory tract infection—Fludarabine—lymphatic system cancer	0.00601	0.00601	CcSEcCtD
Mometasone—Injury—Bleomycin—lymphatic system cancer	0.00597	0.00597	CcSEcCtD
Mometasone—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00567	0.00567	CcSEcCtD
Mometasone—Infection—Mechlorethamine—lymphatic system cancer	0.00564	0.00564	CcSEcCtD
Mometasone—Urinary tract infection—Fludarabine—lymphatic system cancer	0.0056	0.0056	CcSEcCtD
Mometasone—Epistaxis—Fludarabine—lymphatic system cancer	0.00544	0.00544	CcSEcCtD
Mometasone—Anorexia—Mechlorethamine—lymphatic system cancer	0.00541	0.00541	CcSEcCtD
Mometasone—Sinusitis—Fludarabine—lymphatic system cancer	0.00541	0.00541	CcSEcCtD
Mometasone—Injury—Carmustine—lymphatic system cancer	0.00521	0.00521	CcSEcCtD
Mometasone—Pharyngitis—Fludarabine—lymphatic system cancer	0.00514	0.00514	CcSEcCtD
Mometasone—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00493	0.00493	CcSEcCtD
Mometasone—Folliculitis—Methotrexate—lymphatic system cancer	0.00486	0.00486	CcSEcCtD
Mometasone—Bronchospasm—Bleomycin—lymphatic system cancer	0.00466	0.00466	CcSEcCtD
Mometasone—Chest pain—Teniposide—lymphatic system cancer	0.00436	0.00436	CcSEcCtD
Mometasone—Infection—Teniposide—lymphatic system cancer	0.00416	0.00416	CcSEcCtD
Mometasone—Pruritus—Mechlorethamine—lymphatic system cancer	0.00401	0.00401	CcSEcCtD
Mometasone—Anorexia—Teniposide—lymphatic system cancer	0.00399	0.00399	CcSEcCtD
Mometasone—Cough—Fludarabine—lymphatic system cancer	0.00393	0.00393	CcSEcCtD
Mometasone—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00388	0.00388	CcSEcCtD
Mometasone—Arthralgia—Fludarabine—lymphatic system cancer	0.00383	0.00383	CcSEcCtD
Mometasone—Myalgia—Fludarabine—lymphatic system cancer	0.00383	0.00383	CcSEcCtD
Mometasone—Dyspnoea—Teniposide—lymphatic system cancer	0.00373	0.00373	CcSEcCtD
Mometasone—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00368	0.00368	CcSEcCtD
Mometasone—Infection—Fludarabine—lymphatic system cancer	0.00365	0.00365	CcSEcCtD
Mometasone—Decreased appetite—Teniposide—lymphatic system cancer	0.00364	0.00364	CcSEcCtD
Mometasone—Vomiting—Mechlorethamine—lymphatic system cancer	0.00361	0.00361	CcSEcCtD
Mometasone—Urinary tract infection—Carmustine—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Mometasone—Rash—Mechlorethamine—lymphatic system cancer	0.00358	0.00358	CcSEcCtD
Mometasone—Upper respiratory tract infection—Mitoxantrone—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Mometasone—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00357	0.00357	CcSEcCtD
Mometasone—Anorexia—Fludarabine—lymphatic system cancer	0.0035	0.0035	CcSEcCtD
Mometasone—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00342	0.00342	CcSEcCtD
Mometasone—Skin discolouration—Methotrexate—lymphatic system cancer	0.00338	0.00338	CcSEcCtD
Mometasone—Nausea—Mechlorethamine—lymphatic system cancer	0.00337	0.00337	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Mometasone—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Mometasone—Urinary tract infection—Mitoxantrone—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Mometasone—Abdominal pain—Teniposide—lymphatic system cancer	0.00331	0.00331	CcSEcCtD
Mometasone—Body temperature increased—Teniposide—lymphatic system cancer	0.00331	0.00331	CcSEcCtD
Mometasone—Paraesthesia—Fludarabine—lymphatic system cancer	0.0033	0.0033	CcSEcCtD
Mometasone—Dyspnoea—Fludarabine—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Mometasone—Dyspepsia—Fludarabine—lymphatic system cancer	0.00324	0.00324	CcSEcCtD
Mometasone—Ulcer—Methotrexate—lymphatic system cancer	0.00323	0.00323	CcSEcCtD
Mometasone—Sinusitis—Mitoxantrone—lymphatic system cancer	0.00322	0.00322	CcSEcCtD
Mometasone—Decreased appetite—Fludarabine—lymphatic system cancer	0.0032	0.0032	CcSEcCtD
Mometasone—Fatigue—Fludarabine—lymphatic system cancer	0.00317	0.00317	CcSEcCtD
Mometasone—Pain—Fludarabine—lymphatic system cancer	0.00314	0.00314	CcSEcCtD
Mometasone—Rhinitis—Mitoxantrone—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Mometasone—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00306	0.00306	CcSEcCtD
Mometasone—Asthenia—Teniposide—lymphatic system cancer	0.003	0.003	CcSEcCtD
Mometasone—Pruritus—Teniposide—lymphatic system cancer	0.00296	0.00296	CcSEcCtD
Mometasone—Body temperature increased—Fludarabine—lymphatic system cancer	0.00291	0.00291	CcSEcCtD
Mometasone—Cough—Bleomycin—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Mometasone—Diarrhoea—Teniposide—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Mometasone—Mediastinal disorder—Vincristine—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Mometasone—Myalgia—Bleomycin—lymphatic system cancer	0.00281	0.00281	CcSEcCtD
Mometasone—Chest pain—Bleomycin—lymphatic system cancer	0.00281	0.00281	CcSEcCtD
Mometasone—Back pain—Carmustine—lymphatic system cancer	0.00279	0.00279	CcSEcCtD
Mometasone—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.0027	0.0027	CcSEcCtD
Mometasone—Infection—Bleomycin—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Mometasone—Back pain—Vincristine—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Mometasone—Vomiting—Teniposide—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Mometasone—Asthenia—Fludarabine—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Mometasone—Rash—Teniposide—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Mometasone—Dermatitis—Teniposide—lymphatic system cancer	0.00263	0.00263	CcSEcCtD
Mometasone—Headache—Teniposide—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Mometasone—Pruritus—Fludarabine—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Mometasone—Back pain—Mitoxantrone—lymphatic system cancer	0.00259	0.00259	CcSEcCtD
Mometasone—Anorexia—Bleomycin—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Mometasone—Diarrhoea—Fludarabine—lymphatic system cancer	0.00252	0.00252	CcSEcCtD
Mometasone—Nausea—Teniposide—lymphatic system cancer	0.00248	0.00248	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Mometasone—Myalgia—Carmustine—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Mometasone—Chest pain—Carmustine—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Mometasone—Paraesthesia—Bleomycin—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Mometasone—Dyspnoea—Bleomycin—lymphatic system cancer	0.0024	0.0024	CcSEcCtD
Mometasone—Decreased appetite—Bleomycin—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Mometasone—Myalgia—Vincristine—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Mometasone—Cough—Mitoxantrone—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Mometasone—Infection—Carmustine—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Mometasone—Vomiting—Fludarabine—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Mometasone—Rash—Fludarabine—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Mometasone—Dermatitis—Fludarabine—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Mometasone—Pain—Bleomycin—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Mometasone—Headache—Fludarabine—lymphatic system cancer	0.0023	0.0023	CcSEcCtD
Mometasone—Chest pain—Mitoxantrone—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Mometasone—Myalgia—Mitoxantrone—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Mometasone—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Mometasone—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Mometasone—Anorexia—Carmustine—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Mometasone—Infection—Vincristine—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Mometasone—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00219	0.00219	CcSEcCtD
Mometasone—Nausea—Fludarabine—lymphatic system cancer	0.00218	0.00218	CcSEcCtD
Mometasone—Infection—Mitoxantrone—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00214	0.00214	CcSEcCtD
Mometasone—Anorexia—Vincristine—lymphatic system cancer	0.00214	0.00214	CcSEcCtD
Mometasone—Body temperature increased—Bleomycin—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Mometasone—Paraesthesia—Carmustine—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Mometasone—Dyspnoea—Carmustine—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Mometasone—Anorexia—Mitoxantrone—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Mometasone—Decreased appetite—Carmustine—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Mometasone—Paraesthesia—Vincristine—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Mometasone—Pain—Carmustine—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Mometasone—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Mometasone—Decreased appetite—Vincristine—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Mometasone—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Mometasone—Fatigue—Vincristine—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Mometasone—Asthenia—Bleomycin—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Mometasone—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Mometasone—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Mometasone—Pain—Vincristine—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Mometasone—Asthma—Methotrexate—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Mometasone—Pruritus—Bleomycin—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Mometasone—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Mometasone—Fatigue—Mitoxantrone—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Mometasone—Pain—Mitoxantrone—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Mometasone—Abdominal pain—Carmustine—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Mometasone—Body temperature increased—Carmustine—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Mometasone—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Mometasone—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Mometasone—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Mometasone—Abdominal pain—Vincristine—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Mometasone—Body temperature increased—Vincristine—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Mometasone—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Mometasone—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Mometasone—Vomiting—Bleomycin—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Mometasone—Rash—Bleomycin—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Mometasone—Dermatitis—Bleomycin—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Mometasone—Asthenia—Carmustine—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Mometasone—Conjunctivitis—Methotrexate—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Mometasone—Epistaxis—Methotrexate—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Mometasone—Asthenia—Vincristine—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Mometasone—Diarrhoea—Carmustine—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Mometasone—Nausea—Bleomycin—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Mometasone—Asthenia—Mitoxantrone—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Mometasone—Diarrhoea—Vincristine—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Mometasone—Pharyngitis—Methotrexate—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Mometasone—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Mometasone—Vomiting—Carmustine—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Mometasone—Rash—Carmustine—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Mometasone—Dermatitis—Carmustine—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Mometasone—Headache—Carmustine—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Mometasone—Vomiting—Vincristine—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Mometasone—Rash—Vincristine—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Mometasone—Dermatitis—Vincristine—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Mometasone—Headache—Vincristine—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Mometasone—Nausea—Carmustine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Mometasone—Vomiting—Mitoxantrone—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Mometasone—Immune system disorder—Methotrexate—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Mometasone—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Mometasone—Rash—Mitoxantrone—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Mometasone—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Mometasone—Headache—Mitoxantrone—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Mometasone—Nausea—Vincristine—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Mometasone—Nausea—Mitoxantrone—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Mometasone—Back pain—Methotrexate—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Mometasone—Cough—Methotrexate—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Mometasone—Myalgia—Methotrexate—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Mometasone—Chest pain—Methotrexate—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Mometasone—Arthralgia—Methotrexate—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Mometasone—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Mometasone—Infection—Methotrexate—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Mometasone—Anorexia—Methotrexate—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000993	0.000993	CcSEcCtD
Mometasone—Paraesthesia—Methotrexate—lymphatic system cancer	0.000979	0.000979	CcSEcCtD
Mometasone—Dyspnoea—Methotrexate—lymphatic system cancer	0.000972	0.000972	CcSEcCtD
Mometasone—Dyspepsia—Methotrexate—lymphatic system cancer	0.000959	0.000959	CcSEcCtD
Mometasone—Decreased appetite—Methotrexate—lymphatic system cancer	0.000947	0.000947	CcSEcCtD
Mometasone—Fatigue—Methotrexate—lymphatic system cancer	0.00094	0.00094	CcSEcCtD
Mometasone—Pain—Methotrexate—lymphatic system cancer	0.000932	0.000932	CcSEcCtD
Mometasone—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000891	0.000891	CcSEcCtD
Mometasone—Abdominal pain—Methotrexate—lymphatic system cancer	0.000862	0.000862	CcSEcCtD
Mometasone—Body temperature increased—Methotrexate—lymphatic system cancer	0.000862	0.000862	CcSEcCtD
Mometasone—Asthenia—Methotrexate—lymphatic system cancer	0.000782	0.000782	CcSEcCtD
Mometasone—Pruritus—Methotrexate—lymphatic system cancer	0.000771	0.000771	CcSEcCtD
Mometasone—Diarrhoea—Methotrexate—lymphatic system cancer	0.000746	0.000746	CcSEcCtD
Mometasone—Vomiting—Methotrexate—lymphatic system cancer	0.000693	0.000693	CcSEcCtD
Mometasone—Rash—Methotrexate—lymphatic system cancer	0.000687	0.000687	CcSEcCtD
Mometasone—Dermatitis—Methotrexate—lymphatic system cancer	0.000687	0.000687	CcSEcCtD
Mometasone—Headache—Methotrexate—lymphatic system cancer	0.000683	0.000683	CcSEcCtD
Mometasone—Nausea—Methotrexate—lymphatic system cancer	0.000647	0.000647	CcSEcCtD
